Last reviewed · How we verify

Sublingual sildenafil

N4 Pharma UK Ltd. · Phase 3 active Small molecule

Sublingual sildenafil works by increasing blood flow to the penis to treat erectile dysfunction.

Sublingual sildenafil works by increasing blood flow to the penis to treat erectile dysfunction. Used for Erectile dysfunction.

At a glance

Generic nameSublingual sildenafil
Also known asN4S001, Pheonix
SponsorN4 Pharma UK Ltd.
Drug classPhosphodiesterase type 5 inhibitor
TargetPDE5
ModalitySmall molecule
Therapeutic areaUrology
PhasePhase 3

Mechanism of action

Sildenafil is a phosphodiesterase type 5 inhibitor that blocks the action of phosphodiesterase type 5, an enzyme that breaks down cyclic guanosine monophosphate (cGMP) in the smooth muscle cells lining blood vessels. This leads to increased levels of cGMP, causing smooth muscle relaxation and increased blood flow to the penis.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: